Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 4—April 2015
Dispatch

Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010

Orna Mor, Ravit Bassal, Michal Michaeli, Marina Wax, Daniela Ram, Oranit Cohen-Ezra, Dani Cohen, Ella Mendelson, Ziv Ben-Ari, and Tamy Shohat
Author affiliations: Central Virology Laboratory, Ministry of Health, Ramat-Gan, Israel (O. Mor, M. Michaeli, M. Wax, D. Ram, E. Mendelson); Israel Center for Disease Control, Ministry of Health, Ramat-Gan (R. Bassal, T. Shohat); Sheba Medical Center, Ramat-Gan (O. Cohen-Ezra, Z. Ben-Ari); Tel-Aviv University, Tel-Aviv, Israel (D. Cohen, E. Mendelson, T. Shohat)

Main Article

Table 1

Prevalence of antibodies to hepatitis E virus categorized by study population demographics, Israel, 2009–2010*

Characteristics No. samples tested HEV-seropositive samples
 Odds ratio (95% CI) p value
No. % (95% CI)
Age, y
<20 212 1 0.5 (0.01–2.6) Reference
20–39 189 2 1.1 (0.1–3.8) 2.3 (0.2–25.1) 0.51
40–59 168 14 8.3 (4.6–14.0) 19.2 (2.5–147.4) 0.005
≥60
 160
 60
 37.5 (30.0–45.5)
 126.6 (17.3–926.6)
 <0.0001
Sex
M 394 38 9.6 (6.9–13.0) Reference 0.38
F
 335
 39
 11.6 (8.4–15.6)
 1.2 (0.8–2.0)
Birthplace
Israel 518 26 5 (3.3–7.3) Reference <0.0001
Africa, FSU, Asia
 121
 43
 35.5 (27.-44.8)
 10.4 (6.1–17.9)
Population group
Jews 562 58 10.3 (7.9–13.1) Reference 0.002
Arabs
 80
 18
 22.5 (13.9–33.2)
 2.5 (1.4–4.6)
Year of immigration
<1970 89 37 41.6 (31.2–52.5) 2.5 (1.2–5.4) 0.02
1970–1989 31 2 6.4 (0.8–21.4) 0.2 (0.1–1.2) 0.08
1990–2000 54 12 22.2 (12.0–35.6) Reference
>2000
 13
 1
 1 (0.2–36.0)
 0.3 (0.03–2.5)
 0.26
Socioeconomic status
High, ranks 7–10 203 12 5.9 (3.1–10.1) Reference
Intermediate, ranks 4–6 211 25 11.8 (7.8–17.0) 2.1 (1.0–4.4) 0.03
Low, ranks 1–3
 193
 30
 15.5 (10.7–21.4)
 2.9 (1.4–5.9)
 0.003
Total 729 77 10.6 (8.4–13.0) NA NA

*FSU, former Soviet Union; NA, not applicable.

Main Article

Page created: March 17, 2015
Page updated: March 17, 2015
Page reviewed: March 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external